SEC Form 4 · accession 0001179110-17-004610
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erick Wayne DeVinney
Officer — VP, Clinical&Translational Sc
Period of report
Mar 14, 2017
Accepted (ET)
Mar 14, 2017 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 14, 2017 | M | 4,659 | $0.27 | A | 4,659 | D | |
| Common Stock | Mar 14, 2017 | M | 359 | $0.27 | A | 5,018 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to purchase) | $0.27 | Mar 14, 2017 | M | 4,659 | A | Apr 25, 2008 | Apr 25, 2017 | Common Stock | 4,659 | 0 | D |
| Employee Stock Option (right to purchase) | $0.27 | Mar 14, 2017 | M | 359 | A | Dec 6, 2008 | Dec 6, 2017 | Common Stock | 359 | 0 | D |